ReCode Therapeutics, which is developing inhaled mRNA therapeutics for the treatment of primary ciliary dyskinesia and cystic fibrosis, has named John G. Matthews as Senior VP of Clinical Development. ReCode initiated a Phase 1 trial of its RCT1100 nebulized DNAI1 mRNA in March 2023. A pulmonologist, Matthews has extensive experience in respiratory disease research … [Read more...] about ReCode Therapeutics hires John G. Matthews as Senior VP of Clinical Development
People
Gunilla Petersson joins HCmed as Chief Scientific Officer
HCmed Innovations announced that former AstraZeneca Science and Innovation Director of Inhaled Drug Delivery Gunilla Petersson has joined the company as Chief Scientific Officer. Petersson has almost 30 years of experience in the pharmaceutical industry, primarily in inhaled drug development. Taipei-based HCmed launched the Pulmogine handheld mesh nebulizer in … [Read more...] about Gunilla Petersson joins HCmed as Chief Scientific Officer
Kindeva Drug Delivery names David Stevens as Chief Commercial Officer
Former Arranta Bio CEO David Stevens has joined CDMO Kindeva Drug Delivery as Chief Commercial Officer, the company said. Prior to Arranta, Stevens held a variety of roles at Albany Molecular Research, Aptuit, and Charles River Laboratories. Kindeva (formerly 3M Drug Delivery Systems) merged with Meridian Medical Technologies in late 2022. The company's recent … [Read more...] about Kindeva Drug Delivery names David Stevens as Chief Commercial Officer
MannKind names Lauren Sabella as Executive VP, COO
MannKind Corporation has named former Acorda Therapeutics COO Lauren Sabella as Executive VP, Chief Operating Officer. Sabella's experience includes 12 years at Acorda, first as Chief Commercial Officer and then as COO; she previously served in a number of roles at Boehringer Ingelheim, including as Executive Director of Marketing for the Respiratory Franchise and as … [Read more...] about MannKind names Lauren Sabella as Executive VP, COO
In Memoriam: Charles G. Thiel
Charles G. Thiel, one of the most influential scientists working in respiratory drug delivery over the past 7 decades, passed away on March 10, 2023 at the age of 94. In 1956, Thiel and co-workers at Riker Laboratories developed the first pressurized metered dose inhaler for delivery of medication to the lungs. Following the 1970 acquisition of Riker by 3M (now … [Read more...] about In Memoriam: Charles G. Thiel
Bryn Pharma names Sandy Loreaux as CEO
Utuly intranasal epinephrine developer Bryn Pharma has named Sandy Loreaux as CEO, succeeding David Dworaczyk, who will remain with the company as head of R&D, regulatory, and production. Loreaux was most recently US President of Covis Pharma and previously held executive positions at Mallinckrodt, Valeant, and Sanofi-Aventis. Bryn recently announced results … [Read more...] about Bryn Pharma names Sandy Loreaux as CEO
AuraVax names Joseph Sullivan as CEO
AuraVax Therapeutics, which is developing intranasal antiviral technology licensed from Massachusetts General Hospital and the University of Houston, has named former Merck executive Joseph C. Sullivan as the company's first CEO. Sullivan was most recently Chief Commercial Officer at Nature's Toolbox and previously served in various roles at Merck in vaccines, … [Read more...] about AuraVax names Joseph Sullivan as CEO
Savara announces management changes
Inhaled drug developer Savara has announced the appointments of former Strongbridge Biopharma executives Scott Wilhoit as Executive VP, Global Commercial, and Rob Lutz as Chief Operating Officer. The company also said that it had promoted Dave Lowrance from Chief Financial Officer to Chief Financial and Administrative Officer. Wilhoit, who has been a part-time … [Read more...] about Savara announces management changes
PureIMS names Frank Lambert Executive Director of Commercialization
PureIMS has appointed Frank Lambert as Executive Director Commercialization. Lambert, who was most recently Executive Director of Business Development for Early Development Services at ICON, will lead commercialization efforts for the company's Cyclops pre-filled disposable dry powder inhaler. PureIMS has Cyclops DPI formulations of levodopa, epinephrine, and … [Read more...] about PureIMS names Frank Lambert Executive Director of Commercialization
Optinose names Ramy Mahmoud as CEO
Intranasal drug developer Optinose has announced the appointment of Ramy Mahmoud as CEO, succeeding Peter Miller. Mahmoud has served as Optinose's President and Chief Operating Officer since 2010; before joining the company, he served in a number of roles at Johnson & Johnson, including Chief Medical Officer. The company also announced that it expects to submit … [Read more...] about Optinose names Ramy Mahmoud as CEO